This is of note because combined upregulated PLAU and SERPINE1 expression is strongly associated with poor cancer outcomes in various other cancers via mechanisms that affect cell adhesion, ECM remodeling, and signaling pathways leading to increased cell survival, migration, invasion, and angiogenesis (21, 23, 70–73). The gene discussed is PLAU; the disease is cancer.